Price (delayed)
$1.58
Market cap
$90.51M
P/E Ratio
N/A
Dividend/share
N/A
EPS
-$1.18
Enterprise value
$304.42M
Paratek Pharmaceuticals, Inc. is a commercial-stage biopharmaceutical company focused on the development and commercialization of novel life-saving therapies for life-threatening diseases and other public health threats for civilian, government and
There are no recent dividends present for PRTK.
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.